{
    "nct_id": "NCT06325046",
    "official_title": "ART of SABR: A Randomized Phase II Trial of Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer: Two Versus Five Fractions",
    "inclusion_criteria": "* Gender assigned male at birth: age ≥ 18 years\n* Histological confirmation of prostate adenocarcinoma\n* National Comprehensive Cancer Network (NCCN) (Prostate Cancer version 4.2022) low- to intermediate-risk prostate adenocarcinoma\n* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2\n* Ability to complete questionnaire(s) by themselves or with assistance\n* Signed informed consent\n* Willing to complete requirements for follow-up (during active monitoring phase)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* NCCN (Prostate Cancer version 4.2022) very low-, high-, or very high-risk prostate adenocarcinoma\n* Prior definitive treatment of prostate cancer including radiotherapy, prostatectomy, cryotherapy, or high intensity focused ultrasound (HIFU)\n* Prior bladder outlet obstruction procedures including transurethral resection of the prostate (TURP), Holmium laser enucleation of the prostate (HoLEP), transurethral vaporesection of the prostate (TUVRP), etc.\n* Metastatic disease by conventional or molecular imaging\n* Contraindications to radiation therapy (RT) including uncontrolled inflammatory bowel disease, ATM mutation, and Xeroderma pigmentosum mutation\n* Concurrent antineoplastic agents (chemotherapy)\n* Previous or concurrent malignancy other than non-melanoma skin cancer, indolent lymphoma, or chronic myelogenous leukemia, unless continuously disease-free ≥ 5 years\n* Medical or psychiatric conditions that preclude informed decision-making or adherence with the protocol-defined treatment or follow-up\n* Prostate gland volume &gt; 80 cc based on magnetic resonance imaging (MRI), and/or International Prostate Symptom Score (IPSS) composite score &gt; 17\n* Body weight &gt; 200 kilogram\n* Known allergy or sensitivity to polyethylene glycol (PEG) or iodine",
    "miscellaneous_criteria": ""
}